Novel risk factors for lymph node metastasis in early invasive colorectal cancer: A multi-institution pathology review

Journal of Gastroenterology

Volumn 49, Issue 9, 2014, Pages 1314-1323

  Ueno, Hideki ^a   Hase, Kazuo ^a   Hashiguchi, Yojiro ^b   Shimazaki, Hideyuki ^a   Yoshii, Shinji ^c   Kudo, Shin ei ^d   Tanaka, Masafumi ^e   Akagi, Yoshito ^f   Suto, Takeshi ^g   Nagata, Shinji ^h   Matsuda, Keiji ^b   Komori, Koji ⁱ   Yoshimatsu, Kazuhiko ^j   Tomita, Yasuhiko ^k   Yokoyama, Shozo ^l   Shinto, Eiji ^a   Nakamura, Takahiro ^a   Sugihara, Kenichi ^m  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Department of Surgery   (Japan)

^d SHOWA UNIVERSITY   (Japan)

^e TAKANO HOSPITAL   (Japan)

^f KURUME UNIVERSITY   (Japan)

^g Yamagata Prefectural Central Hospital   (Japan)

^h HIROSHIMA CITY ASA HOSPITAL   (Japan)

ⁱ AICHI CANCER CENTER HOSPITAL   (Japan)

^j TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^k OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^l WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^m TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

more..

Author keywords

Endoscopic excision; Lymph node metastases; Poorly differentiated clusters; T1 colorectal cancer; Tumor budding

Indexed keywords

MUCIN;

ADULT; AGED; CANCER CELL; CANCER GRADING; CANCER SURGERY; CELL INFILTRATION; COLORECTAL CANCER; ENDOSCOPIC SURGERY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TUMOR INVASION; CLINICAL TRIAL; COLORECTAL TUMOR; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; RISK FACTORS; YOUNG ADULT;

EID: 84908263241     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0881-3     Document Type: Review

References (55)

1. Repici A, Hassan C, Pessoa DDP, Pagano N, Arezzo A, Zullo A, et al. Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: a systematic review. Endoscopy. 2012;44: 137-47.
2. Kiriyama S, Saito Y, Yamamoto S, Soetikno R, Matsuda T, Nakajima T, et al. Comparison of endoscopic submucosal dissection with laparoscopic-assisted colorectal surgery for earlystage colorectal cancer: a retrospective analysis. Endoscopy. 2012;44:1024-30.
3. Lee EJ, Lee JB, Lee SH, Kim DS, Lee DH, Lee DS, et al. Endoscopic submucosal dissection for colorectal tumors-1000 colorectal ESD cases: one specialized institute's experiences. Surg Endosc 2012 (Epub ahead of print).
4. Cooper HS. Surgical pathology of endoscopically removed malignant polyps of the colon and rectum. Am J Surg Pathol. 1983;7:613-23.
5. Morson BC, Whiteway JE, Jones EA, Macrae FA, Williams CB. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut. 1984;25:437-44.
6. Colacchio TA, Forde KA, Scantlebury VP. Endoscopic polypectomy: inadequate treatment for invasive colorectal carcinoma. Ann Surg. 1981;194:704-7.
7. Sugihara K, Muto T, Morioka Y. Management of patients with invasive carcinoma removed by colonoscopic polypectomy. Dis Colon Rectum. 1989;32:829-34.
8. Cranley JP, Petras RE, Carey WD, Paradis K, Sivak MV. When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology. 1986;91: 419-27.
9. Coverlizza S, Risio M, Ferrari A, Fenoglio-Preiser CM, Rossini FP. Colorectal adenomas containing invasive carcinoma: pathologic assessment of lymph node metastatic potential. Cancer. 1989;64:1937-47.
10. Muller S, Chesner IM, Egan MJ, Rowlands DC, Collard MJ, Swarbrick ET, et al. Significance of venous and lymphatic invasion in malignant polyps of the colon and rectum. Gut. 1989;30:1385-91.
11. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology-colon cancer (version 4. 2013). 2012. http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Accessed Dec 3 2012.
12. Ueno H, Price AB, Wilkinson KH, Jass JR, Mochizuki H, Talbot IC. A new prognostic staging system for rectal cancer. Ann Surg. 2004;240:832-9.
13. Suh JH, Han KS, Kim BC, Hong CW, Sohn DK, Chang HJ, et al. Predictors for lymph node metastasis in T1 colorectal cancer. Endoscopy. 2012;44:590-5.
14. Hassan C, Zullo A, Risio M, Rossini FP, Morini S. Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis Colon Rectum. 2005;48:1588-96.
15. Volk EE, Goldblum JR, Petras RE, Carey WD, Fazio VW. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology. 1995;109:1801-7.
16. Fielding LP, Phillips RKS, Hittinger R. Factors influencing mortality after curative resection for large bowel cancer in elderly patients. Lancet. 1989;18:595-7.
17. Boenicke L, Fein M, Sailer M, Isbert C, Germer C-T, Thalheimer A. The concurrence of histologically positive resection margins and sessile morphology is an important risk factor for lymph node metastasis after complete endoscopic removal of malignant colorectal polyps. Int J Colorectal Dis. 2010;25:433-8.
18. Benizri EI, Bereder J-M, Rahili A, Bernard J-L, Vanbiervliet G, Filippi J, et al. Additional colectomy after colonoscopic polypectomy for T1 colon cancer: a fine balance between oncologic benefit and operative risk. Int J Colorectal Dis. 2012;27:1473-8.
19. Schmoll HJ, Van Cutsem V, Stein A, Valentini V, Glimelius B, Haustermans K, et al.ESMOconsensus guidelines for management of patients with colon and rectal cancer.Apersonalized approach to clinical decision making. Ann Oncol. 2012;23:2479-516.
20. Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2009;17:1-29.
21. Ueno H, Hashiguchi Y, Kajiwara Y, Shinto E, Shimazaki H, Kurihara H, et al. Proposed objective criteria for ''grade 3'' in early invasive colorectal cancer. Am J Clin Pathol. 2010;134: 312-22.
22. Barresi V, Bonetti LR, Branca G, Gregorio CD, de Leon MP, Tuccari G. Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. Virchows Arch. 2012;461:621-8.
23. Ueno H, Shimazaki H, Shinto E, Hashiguchi Y, Nakanishi K, Maekawa K, et al. New criteria for histologic grading of colorectal cancer. Am J Surg Pathol. 2012;36:193-201.
24. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology. 1985;89:328-36.
25. Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127:385-94.
26. Akaike H. Information theory and an extension of the maximum likelihood principle. Budapest: Akademia Kiado; 1973.
27. R Development Core Team. A language and environment for statistical computing. R. Foundation for Statistical Computing; 2006.
28. Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy. 1993;25:455-61.
29. Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, et al. Management of early invasive colorectal cancerrisk of recurrence and clinical guidelines. Dis Colon Rectum. 1995;38:1286-95.
30. Suzuki T, Sadahiro S, Mukoyama S, Ishikawa K, Yasuda S, Tajima T, et al. Risk of lymph node and distant metastases in patients with early invasive colorectal cancer classified as Haggitt's level 4 invasion. Dis Colon Rectum. 2003;46:203-8.
31. Tateishi Y, Nakanishi Y, Taniguchi H, Shimoda T, Uemura S. Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma. Mod Pathol. 2010;23:1068-72.
32. Araki Y, Isomoto H, Shirouzu K, Miura K, Iwanaga H, Okita A, et al. Clinicopathological characteristics of colorectal submucosal carcinoma with lymph node metastasis. Kurume Med J. 1993;40:123-7.
33. Hase K, Shatney CH, Mochizuki H, Johnson DL, Tamakuma S, Vierra M, et al. Long-term results of curative resection of ''minimally invasive'' colorectal cancer. Dis Colon Rectum. 1995;38:19-26.
34. Egashira Y, Yoshida T, Hirata I, Hamamoto N, Akutagawa H, Takeshita A, et al. Analysis of pathological risk factors for lymph node metastasis of submucosal invasive colon cancer. Mod Pathol. 2004;17:503-11.
35. Liang P, Hong J-W, Ubukata H, Liu G, Katano M, Motohashi G, et al. Myofibroblasts correlate with lymphatic microvessel density and lymph node metastasis in early-stage invasive colorectal carcinoma. Anticancer Res. 2005;25:2705-12.
36. Oh-e H, Tanaka S, Kitadai Y, Shimamoto F, Yoshihara M, Haruma K. Angiogenesis at the site of deepest penetration predicts lymph node metastasis of submucosal colorectal cancer. Dis Colon Rectum. 2001;44:1129-36.
37. Sakuragi M, Togashi K, Konishi F, Koinuma K, Kawamura Y, Okada M, et al. Predictive factors for lymph node metastasis in T1 stage colorectal carcinomas. Dis Colon Rectum. 2003;46: 1626-32.
38. Kitajima K, Fujimori T, Fujii S, Takeda J, Ohkura Y, Kawamata H, et al. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaboration study. J Gastroenterol. 2004;39:534-43.
39. Prall E. Tumour budding in colorectal carcinoma. Histopathology. 2007;50:151-62.
40. Lugli A, Karamitopoulou E, Zlobec I. Tumour budding: a promising parameter in colorectal cancer. Br J Cancer. 2012;106: 1713-7.
41. Kaneko I, Shinji S, Oka S, Kawamura T, Hiyama T, Ito M, et al. Lymphatic vessel density at the site of deepest penetration as a predictor of lymph node metastasis in submucosal colorectal cancer. Dis Colon Rectum. 2006;50:13-21.
42. Kaneko I, Tanaka S, Oka S, Yoshida S, Hiyama T, Arihiro K, et al. Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer. World J Gastroenterol. 2007;28:3829-35.
43. Yamauchi H, Togashi K, Kawamura Y, Horie H, Sasaki J, Tsujinaka S, et al. Pathological predictors for lymph node metastasis in T1 colorectal cancer. Surg Today. 2008;38:905-10.
44. Suzuki A, Togashi K, Nokubi M, Koinuma K, Miyakura Y, Horie H, et al. Evaluation of venous invasion by elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer. Am J Surg Pathol. 2009;33:1601-7.
45. Komori K, Hirai T, Kanemitsu Y, Shimizu Y, Sano T, Ito S, et al. Is ''depth of submucosal invasion[=1,000 mm'' an important predictive factor for lymph node metastasis in early invasive colorectal cancer (PT1)? Hepatogastroenterology. 2010;57: 1123-7.
46. Nakadoi K, Tanaka S, Kanao H, Terasaki M, Takata S, Oka S, et al. Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection. J Gastroenterol Hepatol. 2012;27:1057-62.
47. Hamilton SR, Bosman FT, Boffetta P, Ilyas M, Morreau H, Nakamura S-I, et al. Carcinoma of the colon and rectum. In: Bosman FT, Carneiro F, Hruban RH, et al., editors. WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer (IARC); 2010. p. 134-46.
48. Jass JR, O'Brien MJ, Riddell RH, Snover DC. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum Pathol. 2007;38:537-45.
49. The Royal College of Pathologists of Australasia. Colorectal cancer structured reporting protocol, 1st edn. 2010. http://www. rcpa.edu.au. Accessed Feb 19 2013.
50. Williams GT, Quirke P, Shepherd NA, The Royal College of Pathologists. Standards and datasets for reporting cancers. Dataset for colorectal cancer, 2nd edn. 2007. http://www.rcpath.org/ publications-media/publications/datasets/colorectal-cancer.htm. Accessed Feb 19 2013.
51. Kazama S, Watanabe T, Ajioka Y, Kanazawa T, Nagawa H. Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. Br J Cancer. 2006;94: 293-8.
52. Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Yokoo T, Ishii T. Histopathologic determinants of regional lymph node metastasis in early colorectal cancer. Cancer. 2008;112:924-33.
53. Ogawa T, Yoshida T, Tsuruta T, Tokuyama W, Adachi S, Kikuchi M, et al. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths. Scand J Gastroenterol. 2009;44:605-14.
54. Horcic M, Koelzer VH, Karamitopoulou E, Terracciano L, Puppa G, Zlobec I, et al. Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer. Hum Pathol. 2012 (Epub ahead of print).
55. Puppa G, Senore C, Sheahan K, Vieth M, Lugli A, Zlobec I, et al. Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy. Histopathology. 2012 (Epub ahead print).